4.7 Article

Gamma-irradiated resveratrol negatively regulates LPS-induced MAPK and NF-κB signaling through TLR4 in macrophages

期刊

INTERNATIONAL IMMUNOPHARMACOLOGY
卷 25, 期 2, 页码 249-259

出版社

ELSEVIER
DOI: 10.1016/j.intimp.2015.02.015

关键词

Gamma irradiation; Resveratrol; Inflammation; Toll-like receptor 4

资金

  1. Nuclear Research & Development Program of the National Research Foundation - Government of the Republic of Korea [NRF-2012M2A2A6011335]
  2. National Research Foundation of Korea grant - Ministry of Education, Science and Technology [NRF-2012R1A1A2009507]
  3. Kongju National University

向作者/读者索取更多资源

Resveratrol was irradiated at various doses of 15, 30, 50, and 70 kGy for the development of physiological functionalities through modification of the structural properties. Gamma irradiation induced a decrease in the resveratrol peak, and the appearance of several new peaks by gamma irradiation was gradually increased up to 70 kGy. Gamma-irradiated resveratrol did not exert cytotoxicity to macrophages in dose ranges from 15 to 70 kGy; therefore, 70 kGy gamma-irradiated resveratrol was used as the maximum dose throughout subsequent experiments. Treatment of LPS-stimulated macrophages with 70 kGy gamma-irradiated resveratrol resulted in a dose-dependent decrease in iNOS-mediated NO, PGE(2), and pro-inflammatory cytokine level, such as TNF-alpha, IL-6 and IL-1 beta. 70 kGy gamma-irradiated resveratrol significantly inhibited cyclooxygenase-2 levels, as well as the expression of cell surface molecules, such as CD80 and CD86, in LPS-induced macrophages. Furthermore, the inhibitory action of these pro-inflammatory mediators occurred through an inhibition of MAPKs (ERK1/2, p38 and JNK) and NF-kappa B signaling pathways based on a toll-like receptor 4 in macrophages, which may be closely mediated with the radiolysis products of resveratrol transformed by gamma-irradiation. From these findings, it seems likely that gamma irradiation can be an effective tool for a reduction of the toxicity and play a potent role in the treatment of inflammatory disease. (C) 2015 Published by Elsevier B.V.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据